News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Bitterman Kevin
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/17/2023 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Disc Medicine, Inc.
Txns:
| Sold 72,931 shares
@ $52.4, valued at
$3.8M
|
|
06/09/2023 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Disc Medicine, Inc.
Txns:
| Granted 7,136 options to buy
@ $45.69, valued at
$326k
|
|
01/03/2023 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Disc Medicine, Inc.
Txns:
| Granted 7,000 options to buy
@ $13.5, valued at
$94.5k
|
|
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2020 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns:
| Granted 13,000 options to buy
@ $25.2, valued at
$327.6k
|
|
11/12/2019 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns:
| Granted 26,000 options to buy
@ $19.97, valued at
$519.2k
|
|
06/25/2019 |
4
| Bitterman Kevin (Director) has filed a Form 4 on Akero Therapeutics, Inc.
Txns:
| Converted 3,469,759 shares
@ $0 Converted 235,099 shares
@ $0 Bought 270,000 shares
@ $16, valued at
$4.3M
Converted 10,666,667 preferred shares
@ $0 Converted 722,737 preferred shares
@ $0 |
|
06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
12/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/28/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/23/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
11/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/07/2016 |
4
| Bitterman Kevin (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns:
| Granted 15,000 options to buy
@ $4.64, valued at
$69.6k
|
|
|
|